|Articles|July 1, 2007

Pharmacy Times

  • Volume 0
  • 0

MYLAN SCORES VICTORY IN PATENT BATTLE

The latest round in the legal battle over the marketing of generic omeprazole delayedrelease capsules has been won by Mylan Laboratories Inc. A district court in New York ruled that Mylan's generic version of Prilosec does not infringe on AstraZeneca's patents for the popular heartburn drug. At the same time, however, the court held that generic omeprazole products made by 2 other companies, Canada's Apotex Inc and Impax Laboratories Inc in California, do infringe on AstraZeneca's patents.

Articles in this issue

over 18 years ago

pharmacy TECHNOLOGY news

over 18 years ago

pharmacy TECHNOLOGY products

over 18 years ago

health-systems PRODUCT news

over 18 years ago

generic times product news

over 18 years ago

can you READ these Rxs?

over 18 years ago

A closer look at new FDA actions

over 18 years ago

can you READ these Rxs?

over 18 years ago

compounding HOTLINE

over 18 years ago

Is There Science in Quality?

over 18 years ago

Vaccines: Are You Protected?

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME